Herein we report a microscale parallel synthetic approach allowing for rapid access to libraries of N‐acylated aminotriazoles and screening of their inhibitory activity against factor XIIa (FXIIa) and thrombin, which are targets for antithrombotic drugs. This approach, in combination with post‐screening structure optimization, yielded a potent 7 nM inhibitor of FXIIa and a 25 nM thrombin inhibitor; both compounds showed no inhibition of the other tested serine proteases. Selected N‐acylated aminotriazoles exhibited anticoagulant properties in vitro influencing the intrinsic blood coagulation pathway, but not extrinsic coagulation. Mechanistic studies of FXIIa inhibition suggested that synthesized N‐acylated aminotriazoles are covalent inhibitors of FXIIa. These synthesized compounds may serve as a promising starting point for the development of novel antithrombotic drugs.
To counteract thrombosis,
new safe and efficient antithrombotics
are required. We herein report the design, synthesis, and biological
activity of a series of amide-functionalized acylated 1,2,4-triazol-5-amines
as selective inhibitors of blood coagulation factor XIIa and thrombin.
The introduction of an amide moiety into the main scaffold of 3-aryl
aminotriazoles added certain three-dimensional properties to synthesized
compounds and allowed them to reach binding sites in FXIIa and thrombin
previously unaddressed by non-functionalized 1,2,4-triazol-5-amines.
Among synthesized compounds, one quinoxaline-derived aminotriazole
bearing N-butylamide moiety inhibited FXIIa with
the IC50 value of 28 nM, whereas the N-phenylamide-derived aminotriazole inhibited thrombin with the IC50 value of 41 nM. Performed mass-shift experiments and molecular
modeling studies proved the covalent mechanism of FXIIa and thrombin
inhibition by synthesized compounds. In plasma coagulation tests,
developed aminotriazoles showed anticoagulant properties mainly affecting
the intrinsic blood coagulation pathway, activation of which is associated
with thrombosis but is negligible for hemostasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.